Tachycardia, Ventricular Clinical Trial
Official title:
Acute Effect of One Single Bout of High Intensity Exercise. A Substudy of the Study on Physical Activity and Ventricular Arrhythmias
Verified date | April 2023 |
Source | St. Olavs Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will evaluate the acute effect of one single bout of high intensity exercise on the tendency for ventricular arrhythmia.
Status | Completed |
Enrollment | 55 |
Est. completion date | September 2, 2022 |
Est. primary completion date | September 2, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with ICD and dilated cardiomyopathy or coronary heart disease as cause for implantation - ICD implanted at St Olavs hospital, Trondheim In case of difficulties with patient inclusion for the study, the criteria might be broadened to include patients with idiopathic ventricular arrhythmia as cause for implantation. Exclusion Criteria: - inability to accomplish the exercise program due to serious comorbidity or to participate in regular training within the next 3 months due to other reasons - signs of severe cardiac ischemia or persistent ventricular tachycardia during individualized treadmill O2 peak test, which after individual assessment is to be found at risk - comorbidity where endurance training at more than moderate intensity is discouraged - severe cardiac valve disease - planned surgery within the next 3 months - inability to give informed consent |
Country | Name | City | State |
---|---|---|---|
Norway | St Olavs Hospital | Trondheim |
Lead Sponsor | Collaborator |
---|---|
St. Olavs Hospital | Norwegian University of Science and Technology |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Tendency for ventricular arrhythmia | Measured by changes in the number of premature ventricular contractions the first 24 hours after VO2 peak testing compared to the average number of the 48 hours prior to the test. Registered on a 72 hours Holter monitoring | 24 hours | |
Secondary | Changes in ICD-parameters during a single bout of high intensity exercise (VO2 peak test) | Evaluated by changes in number of inappropriate shocks | 24 hours | |
Secondary | Changes in ICD-parameters during a single bout of high intensity exercise (VO2 peak test) | Evaluated by changes in stimulation threshold | 24 hours | |
Secondary | Changes in ICD-parameters during a single bout of high intensity exercise (VO2 peak test) | Evaluated by changes in lead impedance | 24 hours | |
Secondary | Changes in ICD-parameters during a single bout of high intensity exercise (VO2 peak test) | Evaluated by changes in atrial and ventricular refractory period | 24 hours | |
Secondary | Changes in ICD-parameters during a single bout of high intensity exercise (VO2 peak test) | Evaluated by changes in restitution time of the sinus node | 24 hours | |
Secondary | Changes in ICD-parameters during a single bout of high intensity exercise (VO2 peak test) | Evaluated by changes in refractory period of the AV-node | 24 hours | |
Secondary | Changes in acute effect of one single bout of high intensity exercise on tendency for ventricular arrhythmia after either 3 months of interval exercise or control | Measured by changes in the number of premature ventricular contractions the first 24 hours after VO2 peak testing compared to the average number of the 48 hours prior to the test. Registered on a 72 hours Holter monitoring | Baseline and after 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01546207 -
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
|
N/A | |
Completed |
NCT04070300 -
Physical Activity and Ventricular Arrhythmias
|
N/A | |
Completed |
NCT00000531 -
Antiarrhythmics Versus Implantable Defibrillators (AVID)
|
Phase 3 | |
Completed |
NCT00000480 -
Multicenter Unsustained Tachycardia Trial (MUSTT)
|
Phase 3 | |
Completed |
NCT05086510 -
Ablation Targets of Scar-related Ventricular Tachycardia Identified by Dynamic Functional Substrate Mapping
|
N/A | |
Completed |
NCT01940081 -
The Leiden Nonischemic Cardiomyopathy Study
|
||
Recruiting |
NCT01222156 -
Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping
|
Phase 1/Phase 2 | |
Terminated |
NCT00749671 -
Bispectral Index Monitoring During Testing in the Electrophysiology Lab
|
N/A | |
Recruiting |
NCT00385749 -
Right Ventricular Defibrillation Lead Select Site Study
|
N/A | |
Completed |
NCT00382928 -
Automatic External Defibrillation Monitoring in Cardiac Arrest
|
Phase 1 | |
Completed |
NCT00279279 -
PREPARE - Primary Prevention Parameters Evaluation
|
N/A | |
Terminated |
NCT00776087 -
European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco)
|
N/A | |
Withdrawn |
NCT00510731 -
The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events
|
N/A | |
Completed |
NCT01572246 -
Effects of Monopolar Electrocautery Use During Surgery on Implanted Cardiac Defibrillators
|
N/A | |
Completed |
NCT00170287 -
SMS: Substrate Modification Study in Patients Getting an Implantable Cardioverter Defibrillator (ICD)
|
Phase 4 | |
Completed |
NCT00147277 -
ADVANCE-D: Antitachycardia Pacing (ATP) Delivery for Painless Implantable Cardioverter Defibrillator (ICD) Therapy
|
Phase 4 | |
Completed |
NCT00004559 -
Fatty Acid Antiarrhythmia Trial (FAAT)
|
Phase 3 | |
Completed |
NCT00702117 -
Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias
|
Phase 4 | |
Completed |
NCT00232297 -
Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS
|
Phase 2 | |
Active, not recruiting |
NCT01639365 -
SmartTouch Catheter in Ablation of Ventricular Tachycardia
|
N/A |